top of page
CLM-OAB_website-image_edited_edited.jpg

The CARE Study

NEW RESEARCH

OVERACTIVE BLADDER SYNDROME

Struggling with symptoms of Overactive Bladder Syndrome (OAB)?

1 in 10

people are affected by OAB Syndrome1

>90%

of OAB sufferers report lifestyle restrictions2

>80%

of OAB patients treated with sacral neuromodulation experience long-term symptom relief3,4

The CARE Study 

is an approved clinical trial evaluating whether a new
sacral nerve stimulation device could treat symptoms of Overactive Bladder Syndrome
5, 6

WHRIA-Logo.png
Thierry-Vancaillie.png

Principal Investigator
Prof. Thierry Vancaillie

Open for recruitment:
AUSTRALIA
Sydney – Women’s Health & Research Institute of Australia

Adelaide – Better Bladders

better bladders_edited.png
20.png

Principal Investigator
Dr Ailsa Wilson Edwards

The CARE Study
Email: carestudy@mobiusmedical.com.au


HREC Approval 2022-02-103
CTN No. CT-2022-CTN-01202-1-v1
Public Registry No. ACTRN12622000999730

Website managed by Mobius Medical Pty Ltd
Version 1.0 15 June 2022

Trial Sponsor: Closed Loop Medical Pty Ltd 
                        Level 2/5 Eden Park Dr
                        Macquarie Park NSW 2113

Privacy Policy

​# References

  1. Irwin, D.E., Kopp, Z.S., Agatep, B., Milsom, I. and Abrams, P. (2011), Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU International, 108: 1132-1138. https://doi.org/10.1111/j.1464-410X.2010.09993.x

  2. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008 Jun;101(11):1388-95. doi: 10.1111/j.1464-410X.2008.07601.x. PMID: 18454794.

  3. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourol Urodyn. 2021;40(2):714-721. doi:10.1002/nau.24615

  4. Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. The Journal of Urology 2018;Volume 199(1), 229–236.

  5. HREC Approval 2022-02-103

  6. ACTRN12622000999730 

  7. https://www.mayoclinic.org/diseases-conditions/overactive-bladder/symptoms-causes/syc-20355715 

​

bottom of page